Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 42,397,820
- Share change
- +861,366
- Total reported value
- $110,236,742
- Put/Call ratio
- 78%
- Price per share
- $2.60
- Number of holders
- 95
- Value change
- -$9,111,350
- Number of buys
- 57
- Number of sells
- 53
Quarterly Holders Quick Answers
What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03843E104:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
8.2%
|
9,810,958
|
$41,794,681 | — | 31 Mar 2024 | |
| VR Adviser, LLC |
13F
|
Company |
4.6%
|
5,555,555
|
$23,666,664 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
3,242,571
|
$13,813,352 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
2,220,000
|
$9,457,200 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
1.3%
|
1,545,300
|
$6,582,978 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
1,375,800
|
$5,861,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
1,344,876
|
$5,729,171 | — | 31 Mar 2024 | |
| Alexander Mark Schobel |
3/4/5
|
Chief Innovation/Tech Officer |
—
mixed-class rows
|
1,075,726
mixed-class rows
|
$4,804,243 | — | 15 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.83%
|
1,000,000
|
$4,260,000 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.75%
|
897,512
|
$3,823,401 | — | 31 Mar 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.73%
|
875,000
|
$3,727,500 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.71%
|
849,213
|
$3,617,647 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.58%
|
702,941
|
$2,994,529 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.55%
|
665,000
|
$2,832,900 | — | 31 Mar 2024 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.51%
|
612,949
|
$2,611,163 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.5%
|
601,989
|
$2,564,473 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.5%
|
600,592
|
$2,558,522 | — | 31 Mar 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.5%
|
600,000
|
$2,556,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
538,456
|
$2,294,543 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.44%
|
533,567
|
$2,271,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
526,422
|
$2,242,558 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.42%
|
500,000
|
$2,130,000 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.42%
|
500,000
|
$2,130,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
494,445
|
$2,106,336 | — | 31 Mar 2024 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$1,825,712 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.34%
|
414,480
|
$1,765,685 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.32%
|
389,882
|
$1,660,897 | — | 31 Mar 2024 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.28%
|
341,860
|
$1,456,000 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.24%
|
285,360
|
$1,215,000 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.22%
|
263,140
|
$1,120,977 | — | 31 Mar 2024 | |
| Legato Capital Management LLC |
13F
|
Company |
0.21%
|
248,503
|
$1,058,623 | — | 31 Mar 2024 | |
| Latash Investments, LLC |
13F
|
Company |
0.2%
|
243,134
|
$1,035,751 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
224,273
|
$955,403 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.18%
|
222,086
|
$946,086 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.18%
|
219,399
|
$934,640 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
192,856
|
$821,567 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
181,637
|
$773,774 | — | 31 Mar 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.09%
|
108,244
|
$461,119 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.09%
|
102,836
|
$438,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
102,419
|
$436,305 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
97,920
|
$417,140 | — | 31 Mar 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.08%
|
95,813
|
$408,163 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
95,213
|
$405,607 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
92,922
|
$395,848 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.07%
|
90,000
|
$383,400 | — | 31 Mar 2024 | |
| Cahill Wealth Management, LLC |
13F
|
Company |
0.07%
|
86,213
|
$367,268 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.07%
|
85,780
|
$365,422 | — | 31 Mar 2024 | |
| Diametric Capital, LP |
13F
|
Company |
0.06%
|
68,088
|
$290,054 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.05%
|
62,747
|
$267,302 | — | 31 Mar 2024 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.05%
|
60,000
|
$255,600 | — | 31 Mar 2024 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2024
As of 30 Jun 2024,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,397,820 shares.
The largest 10 holders included
Bratton Capital Management, L.P., VR Adviser, LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, Blue Owl Capital Holdings LP, STATE STREET CORP, Janney Montgomery Scott LLC, and Nuveen Asset Management, LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
96
Q2 2024 holders
95
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.